SIMULATED TREATMENT COMPARISON AND MATCHINGADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF EPLONTERSEN AND VUTRISIRAN FOR THE TREATMENT OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY

被引：0
|
作者：
Karam, C. [1 ]
Gillmore, J. D. [2 ]
Chen, G. [3 ]
Jenkins, N. C. [4 ]
Hale, M. J. [4 ]
Chen, J. [5 ]
Viney, N. J. [6 ]
Schneider, E. [6 ]
机构：
[1] Univ Penn, Dept Neurol, Philadelphia, PA USA
[2] UCL, Royal Free Hosp, Div Med, Natl Amyloidosis Ctr, London, England
[3] AstraZeneca, Cambridge, England
[4] Hlth Econ & Outcomes Res Ltd, Cardiff, Wales
[5] AstraZeneca, Gaithersburg, MD USA
[6] Ionis Pharmaceut Inc, Carlsbad, CA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO183
引用
收藏
页码：S46 / S47
页数：2
相关论文
共 50 条
  • [1] Evaluation of methodologies for indirect comparison of eplontersen and vutrisiran for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Karam, Chafic
    Gillmore, Julian
    Chen, Gengshi
    Jenkins, Nia
    Hale, Mike
    Taylor, Gemma
    Chen, Jersey
    Viney, Nicholas
    Schneider, Eugene
    NEUROLOGY, 2023, 100 (17)
  • [2] A MULTI-METHOD APPROACH TO AN INDIRECT TREATMENT COMPARISON OF EPLONTERSEN AND VUTRISIRAN FOR THE TREATMENT OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Karam, C.
    Gillmore, J. D.
    Chen, G.
    Jenkins, N. C.
    Hale, M. J.
    Taylor, G. M.
    Chen, J.
    Viney, N. J.
    Schneider, E.
    VALUE IN HEALTH, 2023, 26 (06) : S279 - S279
  • [3] Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Merkel, Madeline
    Danese, David
    Chen, Chongshu
    Wang, Jessie
    Wu, Aozhou
    Yang, Hongbo
    Lin, Hollis
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (10) : 1205 - 1214
  • [4] An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Plante-Bordeneuve, Violaine
    Lin, Hollis
    Gollob, Jared
    Agarwal, Sonalee
    Betts, Marissa
    Fahrbach, Kyle
    Chitnis, Madhura
    Polydefkis, Michael
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (04) : 473 - 481
  • [5] Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Gorevic, Peter
    Franklin, Jaclyn
    Chen, Jihong
    Sajeev, Gautam
    Wang, Jessie C. H.
    Lin, Hollis
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (01) : 121 - 129
  • [6] A mini-review of Vutrisiran and Eplontersen in hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Olatunji, Gbolahan
    Kokori, Emmanuel
    Abraham, Israel Charles
    Omoworare, Oluwatobi
    Olatunji, Doyin
    Ezeano, Chimezirim
    Emmanuel Adeoba, Babawale
    Stanley, Anthony Chidera
    Oluwatobiloba, Awoyinfa Michael
    Oluwademilade, Omidiran Basit
    Shimelis, Kale Mekoya
    Olanisa, Olawale
    Aderinto, Nicholas
    MEDICINE, 2024, 103 (26) : e38767
  • [7] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Tina Nie
    Young-A Heo
    Matt Shirley
    Drugs, 2023, 83 : 1425 - 1432
  • [8] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Nie, Tina
    Heo, Young-A
    Shirley, Matt
    DRUGS, 2023, 83 (15) : 1425 - 1432
  • [9] Response to the letter to the editor on "an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy"
    Lin, Hollis
    Agarwal, Sonalee
    Betts, Marissa
    Fahrbach, Kyle
    Chitnis, Madhura
    Polydefkis, Michael
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (12) : 1529 - 1530
  • [10] Letter to the editor concerning the article: "An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy"
    Salvo, E. M.
    Samjoo, I. A.
    Tran, D.
    Cameron, C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (12) : 1527 - 1528
12345